Conditions: Adults With Overweight/Obesity and Type 2 Diabetes
Interventions: Drug: AT673 low dose; Drug: AT673 high dose; Drug: Placebo
Sponsors: Antag Therapeutics
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
